Letters and drug alerts sent to healthcare professionals in August 2018
Letters were sent about daclizumab beta (Zinbryta▼), alteplase (Actilyse), Esmya (ulipristal acetate), and Xofigo▼ (radium-223-dichloride). MHRA issued alerts and recalls for batches of Nutriflex Omega Special 2500 ml and Nutriflex Lipid Special 2500 ml.
In August 2018, the following letters were sent from marketing authorisation holders to healthcare professionals about the safety of medicines:
-
Esmya (ulipristal acetate):
-
Xofigo (radium-223-dichloride):
-
Daclizumab beta (Zinbryta▼):
-
Alteplase (Actilyse) in acute ischaemic stroke:
In August 2018, MHRA issued the following Alerts and recalls for drugs:
-
Nutriflex Omega Special 2500 ml: Company-led recall 20 August 2018 – B. Braun Medical Ltd are recalling specific batches of Nutriflex Omega Special 2500 ml as it has been identified that these may have an out of specification result in the glucose chamber at the end of their shelf life.
-
Nutriflex Lipid Special without Electrolytes 2500 ml: Company-led recall 23 August 2018 – B. Braun Medical Ltd are recalling specific batches of Nutriflex Lipid Special without Electrolytes 2500 ml as it has been identified that these may have an out of specification result in the glucose chamber at the end of their shelf life